Concure Oncology

Mercer Island, United States Founded: 2014 • Age: 12 yrs
Breast microseed radiotherapy for early-stage breast cancer is developed.

About Concure Oncology

Concure Oncology is a company based in Mercer Island (United States) founded in 2014.. Concure Oncology has raised $14.04 million across 6 funding rounds from investors including Cascadia Venture Forum. Concure Oncology operates in a competitive market with competitors including Koya Medical, Sensus Healthcare, Theragenics, Eckert & Ziegler BEBIG and C4 Imaging, among others.

  • Headquarter Mercer Island, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $14.04 M (USD)

    in 6 rounds

  • Latest Funding Round
    $7.46 M (USD), Series A

    Aug 07, 2020

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Concure Oncology

Concure Oncology has successfully raised a total of $14.04M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $7.46 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series A — $7.5M
  • First Round

    (04 Dec 2015)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2020 Amount Series A - Concure Oncology Valuation

investors

Sep, 2019 Amount Series A - Concure Oncology Valuation

investors

Dec, 2017 Amount Seed - Concure Oncology Valuation Cascadia Venture Forum
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Concure Oncology

Concure Oncology has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Cascadia Venture Forum. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Concure Oncology

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Concure Oncology

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Concure Oncology Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Concure Oncology

Concure Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Koya Medical, Sensus Healthcare, Theragenics, Eckert & Ziegler BEBIG and C4 Imaging, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of smart wearable compression technology for lymphedema and venous diseases
domain founded_year HQ Location
Non-invasive skin cancer treatments are developed and marketed.
domain founded_year HQ Location
Manufacturer of surgical products and brachytherapy devices
domain founded_year HQ Location
Brachytherapy devices are developed for prostate, breast, and gynecological cancers.
domain founded_year HQ Location
Image-guided procedures for prostate cancer treatment are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Concure Oncology

Frequently Asked Questions about Concure Oncology

When was Concure Oncology founded?

Concure Oncology was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is Concure Oncology located?

Concure Oncology is headquartered in Mercer Island, United States. It is registered at Mercer Island, Washington, United States.

Is Concure Oncology a funded company?

Concure Oncology is a funded company, having raised a total of $14.04M across 6 funding rounds to date. The company's 1st funding round was a Seed of $825K, raised on Dec 04, 2015.

What does Concure Oncology do?

Concure Oncology provides an innovative cancer treatment for women diagnosed with early-stage breast cancer. The company has developed a proprietary technology, Breast Microseed Treatment involves the use of Brancy therapy for the precise placement of radioactive seeds in the breast that slowly release the prescribed dose safely over time. This radiation therapy will help the women with early-stage breast cancer to prevent the recurrence of cancer by treating the surgical site and surrounding tissue after the cancerous tumor is removed.

Who are the top competitors of Concure Oncology?

Concure Oncology's top competitors include Koya Medical, Sensus Healthcare and RadioGel.

Who are Concure Oncology's investors?

Concure Oncology has 1 investor. Key investors include Cascadia Venture Forum.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available